Portfolio Holdings Detail for ISIN IE0009QS7W62
Stock Name / FundMSCI Wld Hlth US A
Issuer
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerWHCA(EUR) Euronext Amsterdam

Holdings detail for EXAS

Stock NameEXACT Sciences Corporation
TickerEXAS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS30063P1057
LEI549300VM3X1FYD4N9Z14

Show aggregate EXAS holdings

News associated with EXAS

Cerity Partners LLC Boosts Stake in Exact Sciences Co. (NASDAQ:EXAS)
Cerity Partners LLC lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 65.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 27,090 shares of the medical research company’s stock after acquiring an additional 10,761 shares during the period. Cerity Partners LLC’s holdings […] - 2025-04-18 08:00:55
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Alliancebernstein L.P.
Alliancebernstein L.P. lowered its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 92.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,845 shares of the medical research company’s stock after selling 890,747 shares during the quarter. Alliancebernstein L.P.’s holdings in Exact […] - 2025-04-15 07:50:49
How The Pieces Add Up: USCA Targets $43
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-07 12:01:03
CIBC Private Wealth Group LLC Decreases Holdings in Exact Sciences Co. (NASDAQ:EXAS)
CIBC Private Wealth Group LLC lowered its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 3,357 shares of the medical research company’s stock after selling 426 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Exact Sciences were worth $190,000 at […] - 2025-04-07 08:04:59
Mitsubishi UFJ Trust & Banking Corp Has $4.50 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)
Mitsubishi UFJ Trust & Banking Corp cut its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 80,058 shares of the medical research company’s stock after selling […] - 2025-03-31 08:40:55
Corient Private Wealth LLC Sells 13,018 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Corient Private Wealth LLC trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 40.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,813 shares of the medical research company’s stock after selling 13,018 shares during the period. […] - 2025-03-27 08:42:59
Intech Investment Management LLC Trims Position in Exact Sciences Co. (NASDAQ:EXAS)
Intech Investment Management LLC reduced its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 70.3% during the 4th quarter, Holdings Channel reports. The fund owned 3,560 shares of the medical research company’s stock after selling 8,426 shares during the period. Intech Investment Management LLC’s holdings in Exact Sciences were worth $200,000 as of […] - 2025-03-27 08:03:08
Exact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty research firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and eighteen have assigned a buy recommendation to the company. The average 1-year […] - 2025-03-24 06:08:55
M&T Bank Corp Sells 1,293 Shares of Exact Sciences Co. (NASDAQ:EXAS)
M&T Bank Corp lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,963 shares of the medical research company’s stock after selling 1,293 shares during the period. M&T Bank […] - 2025-03-14 08:08:55
SBI Securities Co. Ltd. Makes New Investment in Exact Sciences Co. (NASDAQ:EXAS)
SBI Securities Co. Ltd. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,183 shares of the medical research company’s stock, valued at approximately $66,000. A number of other large investors […] - 2025-03-10 07:46:54
Proficio Capital Partners LLC Makes New Investment in Exact Sciences Co. (NASDAQ:EXAS)
Proficio Capital Partners LLC purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 28,545 shares of the medical research company’s stock, valued at approximately $1,604,000. A number of other institutional investors and hedge funds have […] - 2025-03-07 09:26:49
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Private Advisor Group LLC
Private Advisor Group LLC lowered its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,796 shares of the medical research company’s stock after selling 2,253 shares during the quarter. Private Advisor Group […] - 2025-02-28 09:15:01
First Horizon Advisors Inc. Sells 502 Shares of Exact Sciences Co. (NASDAQ:EXAS)
First Horizon Advisors Inc. decreased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 20.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,970 shares of the medical research company’s stock after selling 502 shares during the period. First Horizon Advisors Inc.’s holdings in Exact Sciences were worth $111,000 as of its […] - 2025-02-27 09:05:00
Exact Sciences (NASDAQ:EXAS) Trading Up 4.8% on Analyst Upgrade
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) shares traded up 4.8% during mid-day trading on Monday after Scotiabank raised their price target on the stock from $70.00 to $73.00. Scotiabank currently has a sector outperform rating on the stock. Exact Sciences traded as high as $51.50 and last traded at $51.64. 762,199 shares changed […] - 2025-02-25 06:04:51
CIBC Asset Management Inc Has $416,000 Holdings in Exact Sciences Co. (NASDAQ:EXAS)
CIBC Asset Management Inc raised its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,396 shares of the medical research company’s stock after acquiring an additional 907 shares […] - 2025-02-24 10:06:54
Rhumbline Advisers Sells 5,997 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Rhumbline Advisers lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 217,428 shares of the medical research company’s stock after selling 5,997 shares during the quarter. Rhumbline Advisers’ holdings in Exact Sciences were worth $12,217,000 as of its […] - 2025-02-24 09:04:55
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc.
Principal Financial Group Inc. cut its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 22.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 808,515 shares of the medical research company’s stock after selling 240,741 shares during the period. Principal Financial Group Inc. owned 0.44% […] - 2025-02-21 09:49:09
Van ECK Associates Corp Sells 13,023 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Van ECK Associates Corp trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 122,842 shares of the medical research company’s stock after selling 13,023 shares during the […] - 2025-02-18 08:36:53
Brokerages Set Exact Sciences Co. (NASDAQ:EXAS) Target Price at $72.76
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) has been given an average rating of “Moderate Buy” by the nineteen research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eighteen have issued a buy rating on the company. The average 1 year price […] - 2025-02-05 06:38:52
Exchange Traded Concepts LLC Sells 843 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Exchange Traded Concepts LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 11,669 shares of the medical research company’s stock after selling 843 shares during the period. Exchange Traded Concepts LLC’s holdings in […] - 2025-01-30 08:53:03

MSCI Wld Hlth US A EXAS holdings

DateNumber of EXAS Shares HeldBase Market Value of EXAS SharesLocal Market Value of EXAS SharesChange in EXAS Shares HeldChange in EXAS Base ValueCurrent Price per EXAS Share HeldPrevious Price per EXAS Share Held
2025-04-17 (Thursday)4,295USD 178,586USD 178,586
2025-04-16 (Wednesday)4,295USD 181,507EXAS holding decreased by -6056USD 181,5070USD -6,056 USD 42.2601 USD 43.6701
2025-04-15 (Tuesday)4,295USD 187,563EXAS holding decreased by -2491USD 187,5630USD -2,491 USD 43.6701 USD 44.2501
2025-04-14 (Monday)4,295USD 190,054EXAS holding decreased by -859USD 190,0540USD -859 USD 44.2501 USD 44.4501
2025-04-11 (Friday)4,295USD 190,913EXAS holding increased by 3050USD 190,9130USD 3,050 USD 44.4501 USD 43.7399
2025-04-10 (Thursday)4,295USD 187,863EXAS holding decreased by -7560USD 187,8630USD -7,560 USD 43.7399 USD 45.5001
2025-04-09 (Wednesday)4,295USD 195,423EXAS holding increased by 22292USD 195,4230USD 22,292 USD 45.5001 USD 40.3099
2025-04-08 (Tuesday)4,295USD 173,131EXAS holding decreased by -15119USD 173,1310USD -15,119 USD 40.3099 USD 43.83
2025-04-07 (Monday)4,295USD 188,250EXAS holding increased by 5498USD 188,2500USD 5,498 USD 43.83 USD 42.5499
2025-04-04 (Friday)4,295USD 182,752EXAS holding decreased by -8633USD 182,7520USD -8,633 USD 42.5499 USD 44.56
2025-04-02 (Wednesday)4,295USD 191,385EXAS holding increased by 4767USD 191,3850USD 4,767 USD 44.56 USD 43.4501
2025-04-01 (Tuesday)4,295USD 186,618EXAS holding increased by 687USD 186,6180USD 687 USD 43.4501 USD 43.2901
2025-03-31 (Monday)4,295USD 185,931EXAS holding decreased by -1589USD 185,9310USD -1,589 USD 43.2901 USD 43.6601
2025-03-28 (Friday)4,295USD 187,520EXAS holding decreased by -5712USD 187,5200USD -5,712 USD 43.6601 USD 44.99
2025-03-27 (Thursday)4,295USD 193,232EXAS holding increased by 301USD 193,2320USD 301 USD 44.99 USD 44.9199
2025-03-26 (Wednesday)4,295USD 192,931EXAS holding decreased by -3222USD 192,9310USD -3,222 USD 44.9199 USD 45.6701
2025-03-25 (Tuesday)4,295EXAS holding increased by 51USD 196,153EXAS holding decreased by -3697USD 196,15351USD -3,697 USD 45.6701 USD 47.09
2025-03-24 (Monday)4,244USD 199,850EXAS holding increased by 6239USD 199,8500USD 6,239 USD 47.09 USD 45.6199
2025-03-21 (Friday)4,244USD 193,611EXAS holding increased by 5687USD 193,6110USD 5,687 USD 45.6199 USD 44.2799
2025-03-20 (Thursday)4,244USD 187,924EXAS holding decreased by -6027USD 187,9240USD -6,027 USD 44.2799 USD 45.7
2025-03-19 (Wednesday)4,244USD 193,951EXAS holding increased by 3311USD 193,9510USD 3,311 USD 45.7 USD 44.9199
2025-03-18 (Tuesday)4,244USD 190,640EXAS holding decreased by -1104USD 190,6400USD -1,104 USD 44.9199 USD 45.18
2025-03-17 (Monday)4,244USD 191,744EXAS holding increased by 764USD 191,7440USD 764 USD 45.18 USD 45
2025-03-14 (Friday)4,244USD 190,980EXAS holding increased by 8318USD 190,9800USD 8,318 USD 45 USD 43.0401
2025-03-13 (Thursday)4,244USD 182,662EXAS holding decreased by -14047USD 182,6620USD -14,047 USD 43.0401 USD 46.3499
2025-03-12 (Wednesday)4,244USD 196,709EXAS holding increased by 1952USD 196,7090USD 1,952 USD 46.3499 USD 45.89
2025-03-11 (Tuesday)4,244USD 194,757EXAS holding increased by 3904USD 194,7570USD 3,904 USD 45.89 USD 44.9701
2025-03-10 (Monday)4,244USD 190,853EXAS holding decreased by -8870USD 190,8530USD -8,870 USD 44.9701 USD 47.0601
2025-03-07 (Friday)4,244EXAS holding decreased by -107USD 199,723EXAS holding decreased by -7515USD 199,723-107USD -7,515 USD 47.0601 USD 47.63
2025-03-05 (Wednesday)4,351USD 207,238USD 207,238
2024-11-12 (Tuesday)4,509USD 226,171USD 226,171
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EXAS by for IE0009QS7W62

Show aggregate share trades of EXAS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-25BUY51 45.670* 45.42
2025-03-07SELL-107 47.060* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EXAS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-04-17677,6845131,510,12344.9%
2025-04-16497,81951,4041,423,43335.0%
2025-04-15288,134180589,70248.9%
2025-04-14535,273987852,71962.8%
2025-04-11426,6382821,219,98735.0%
2025-04-10644,1282881,339,93948.1%
2025-04-091,120,7204,0212,220,59150.5%
2025-04-08976,6535,9732,089,59946.7%
2025-04-071,158,30324,1432,569,27245.1%
2025-04-04881,8743,5502,042,34343.2%
2025-04-03687,59101,169,63258.8%
2025-04-02461,8921,798666,42569.3%
2025-04-01691,1966,4231,134,69060.9%
2025-03-31230,405923512,78744.9%
2025-03-28218,579178587,08837.2%
2025-03-27271,61846559,00148.6%
2025-03-26335,38610,934548,98561.1%
2025-03-25282,05324,335539,21852.3%
2025-03-24379,899938551,46368.9%
2025-03-21387,026210518,80474.6%
2025-03-20254,1372586,57843.3%
2025-03-19372,38512,200560,78966.4%
2025-03-18322,3082,694821,14039.3%
2025-03-17295,562122710,31041.6%
2025-03-14362,189112616,01158.8%
2025-03-131,103,6443221,599,48969.0%
2025-03-12392,14729,614608,98864.4%
2025-03-11401,48318,160614,24565.4%
2025-03-10616,7364571,186,56852.0%
2025-03-07637,5524611,070,87959.5%
2025-03-06485,6361,635748,77464.9%
2025-03-05457,60974742,41561.6%
2025-03-041,001,5971601,493,32767.1%
2025-03-03639,526496916,45669.8%
2025-02-28893,8666,8171,457,21061.3%
2025-02-27579,0312011,176,95549.2%
2025-02-26454,46697,713894,59350.8%
2025-02-25491,886345941,01952.3%
2025-02-24500,706536924,48154.2%
2025-02-21662,2447261,357,12648.8%
2025-02-201,763,7351,1002,582,69968.3%
2025-02-19566,5511,6131,303,81343.5%
2025-02-18414,2591401,139,14636.4%
2025-02-14287,805190826,52134.8%
2025-02-13366,4225,749807,45645.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.